Last10K.com

Cyanotech Corp (CYAN) SEC Filing 10-K Annual report for the fiscal year ending Sunday, March 31, 2019

Cyanotech Corp

CIK: 768408 Ticker: CYAN
Document And Entity Information - USD ($)
12 Months Ended
Mar. 31, 2019
Jun. 17, 2019
Sep. 30, 2018
Document Information [Line Items]   
Entity Registrant NameCyanotech Corp  
Entity Central Index Key0000768408  
Trading Symbolcyan  
Current Fiscal Year End Date--03-31  
Entity Filer CategoryNon-accelerated Filer  
Entity Current Reporting StatusYes  
Entity Voluntary FilersNo  
Entity Well-known Seasoned IssuerNo  
Entity Emerging Growth Companyfalse  
Entity Small Businesstrue  
Entity Common Stock, Shares Outstanding (in shares) 5,889,582 
Entity Public Float  $ 10,163,739
Entity Shell Companyfalse  
Document Type10-K  
Document Period End DateMar. 31, 2019  
Document Fiscal Year Focus2019  
Document Fiscal Period FocusFY  
Amendment Flagfalse  

View differences made from one year to another to evaluate Cyanotech Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cyanotech Corp.

Continue

Assess how Cyanotech Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cyanotech Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Other
Filter Subcategory:
All
Debt
Product
Expense
Earnings
Cash Flow
Income
Other
Inside Cyanotech Corp's 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Consolidated Statements Of Stockholders' Equity
Note 1 - Organization And Basis Of Presentation
Note 1 - Organization And Basis Of Presentation (Details Textual)
Note 10 - Share-Based Compensation
Note 10 - Share-Based Compensation (Details Textual)
Note 10 - Share-Based Compensation (Tables)
Note 10 - Share-Based Compensation - Restricted Stock Units (Details)
Note 10 - Share-Based Compensation - Shares Authorized, Available For Future Grant And Outstanding Under Each Plan (Details)
Note 10 - Share-Based Compensation - Summary Of Non-Vested Options (Details)
Note 10 - Share-Based Compensation - Summary Of Option Activity Under Stock Plans (Details)
Note 10 - Share-Based Compensation - Summary Of The Weighted-Average Characteristics Of Outstanding Stock Options (Details)
Note 10 - Share-Based Compensation - Summary Of Valuation Assumptions Related To Options Granted (Details)
Note 11 - Common And Preferred Stock
Note 11 - Common And Preferred Stock (Details Textual)
Note 12 - (Loss) Earnings Per Share
Note 12 - (Loss) Earnings Per Share (Details Textual)
Note 12 - (Loss) Earnings Per Share (Tables)
Note 12 - (Loss) Earnings Per Share - Summary Of Reconciliations Between The Numerator And The Denominator Of The Basic And Diluted Earnings Per Share Computations (Details)
Note 13 - Profit Sharing Plan And 401K Plan
Note 13 - Profit Sharing Plan And 401K Plan (Details Textual)
Note 14 - Product Line And Geographic Information
Note 14 - Product Line And Geographic Information (Tables)
Note 14 - Product Line And Geographic Information - Net Sales By Product Line (Details)
Note 14 - Product Line And Geographic Information - Sales By Geographic Region (Details)
Note 15 - Income Taxes
Note 15 - Income Taxes (Details Textual)
Note 15 - Income Taxes (Tables)
Note 15 - Income Taxes - Components Of Income Tax Benefit (Expense) (Details)
Note 15 - Income Taxes - Effects Of Temporary Differences Related To Various Assets, Liabilities And Carry Forwards That Give Rise To Deferred Tax Assets And Liabilities (Details)
Note 15 - Income Taxes - Net Operating Loss Carry Forwards And Tax Credit Carry Forwards Available To Offset Future Federal Income Tax (Details)
Note 15 - Income Taxes - Open Tax Years And Jurisdictions That The Company Used In Its Evaluation Of Tax Positions (Details)
Note 15 - Income Taxes - Reconciliation Of The Amount Of Income Taxes Computed At The Federal Statutory Rate To The Amount Reflected In Consolidated Statements Of Operations (Details)
Note 15 - Income Taxes - Refundable Alternative Minimum Tax Credit Carryforwards (Details)
Note 16 - Related-Party Transactions And Balances
Note 16 - Related-Party Transactions And Balances (Details Textual)
Note 17 - Subsequent Events
Note 17 - Subsequent Events (Details Textual)
Note 18 - Selected Quarterly Financial Data (Unaudited)
Note 18 - Selected Quarterly Financial Data (Unaudited) (Tables)
Note 18 - Selected Quarterly Financial Data (Unaudited) - Quarterly Financial Information (Unaudited) (Details)
Note 2 - Significant Accounting Polices - Reconciliation Of Cash And Restricted Cash (Details)
Note 2 - Significant Accounting Policies
Note 2 - Significant Accounting Policies (Details Textual)
Note 2 - Significant Accounting Policies (Tables)
Note 2 - Significant Accounting Policies - Estimated Useful Lives (Details)
Note 3 - Inventories
Note 3 - Inventories (Details Textual)
Note 3 - Inventories (Tables)
Note 3 - Inventories - Components Of Inventory (Details)
Note 4 - Equipment And Leasehold Improvements
Note 4 - Equipment And Leasehold Improvements (Details Textual)
Note 4 - Equipment And Leasehold Improvements (Tables)
Note 4 - Equipment And Leasehold Improvements, Net - Components Of Equipment And Leasehold Improvements (Details)
Note 5 - Short-Term Contract Obligations
Note 5 - Short-Term Contract Obligations (Details Textual)
Note 6 - Line Of Credit And Long-Term Debt
Note 6 - Line Of Credit And Long-Term Debt (Details Textual)
Note 6 - Line Of Credit And Long-Term Debt (Tables)
Note 6 - Line Of Credit And Long-Term Debt - Future Payments (Details)
Note 6 - Line Of Credit And Long-Term Debt - Summary Of Line Of Credit And Long-Term Debt (Details)
Note 7 - Accrued Expenses
Note 7 - Accrued Expenses (Tables)
Note 7 - Accrued Expenses - Components Of Accrued Expenses (Details)
Note 8 - Operating Leases
Note 8 - Operating Leases (Details Textual)
Note 8 - Operating Leases (Tables)
Note 8 - Operating Leases - Summary Of Future Minimum Lease Payments Under Non-Cancelable Operating Leases (Details)
Note 9 - Other Commitments And Contingencies
Note 9 - Other Commitments And Contingencies (Details Textual)
Schedule Ii - Valuation And Qualifying Accounts
Schedule Ii - Valuation And Qualifying Accounts (Tables)
Schedule Ii - Valuation And Qualifying Accounts - Valuation And Qualifying Accounts (Details)
Significant Accounting Policies (Policies)
Ticker: CYAN
CIK: 768408
Form Type: 10-K Annual Report
Accession Number: 0001437749-19-013217
Submitted to the SEC: Mon Jul 01 2019 12:04:13 PM EST
Accepted by the SEC: Mon Jul 01 2019
Period: Sunday, March 31, 2019
Industry: Medicinal Chemicals And Botanical Products

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/cyan/0001437749-19-013217.htm